Core Laboratories (CLB) Net Cash Flow (2022 - 2026)

Core Laboratories' Net Cash Flow history runs 5 years deep, the most recent figure standing at $117000.0 for Q1 2026.

• On a quarterly basis, Net Cash Flow fell 96.03% year-over-year to $117000.0 in Q1 2026; TTM through Mar 2026 was $712000.0, a 90.1% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 12.19% from the prior year.
• Net Cash Flow advanced to $117000.0 in Q1 2026 per CLB's latest filing, from -$2.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $9.9 million in Q2 2023 and bottomed at -$9.6 million in Q3 2023.
• The 5-year median for Net Cash Flow is $117000.0 (2026), against an average of $444733.3.
• Across the five-year window, Net Cash Flow sank 296.85% in 2023 and jumped 1525.12% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $1.7 million in 2022, then tumbled by 188.21% to -$1.5 million in 2023, then sank by 54.88% to -$2.3 million in 2024, then dropped by 26.33% to -$2.9 million in 2025, then jumped by 104.0% to $117000.0 in 2026.
• Per Business Quant, the three latest CLB Net Cash Flow figures stand at $117000.0 (Q1 2026), -$2.9 million (Q4 2025), and -$5.6 million (Q3 2025).